The Microchimerism,
Human Health &
Evolution Project
Mission
We aim to advance fundamental understanding of microchimerism and its role in human health and disease through the development and applications of phenotyping microchimeric cells and host immune systems. Our approach will allow us to characterize microchimerism in various tissues and environments, ranging from healthy pregnancies (mouse and human) to disease states (auto-immune diseases, pregnancy complications).
The Microchimerism, Human Health
and Evolution Project
Mission
We aim to advance fundamental understanding of microchimerism and its role in human health and disease through the development and applications of phenotyping microchimeric cells and host immune systems. Our approach will allow us to characterize microchimerism in various tissues and environments, ranging from healthy pregnancies (mouse and human) to disease states (auto-immune diseases, pregnancy complications).
We are all multitudes
Microchimerism is the presence of cells from one individual in another genetically distinct individual.
The Microchimerism, Human Health and Evolution Project
Mission
We aim to advance fundamental understanding of microchimerism and its role in human health and disease through the development and applications of phenotyping microchimeric cells and host immune systems. Our approach will allow us to characterize microchimerism in various tissues and environments, ranging from healthy pregnancies (mouse and human) to disease states (auto-immune diseases, pregnancy complications).
Kroneis is a leader in rare cell analysis at the single cell level and a specialist regarding techniques necessary to sample, unambiguously discriminate and characterize single haplo-identical (i.e., maternal and fetal) cells.
Thomas Kroneis
Co-Principle Investigator
Medical University of Graz
Boddy is is a human biologist and evolutionary theorist. Her work integrates maternal/fetal conflict theory, evolution of the placenta and the consequences of fetal microchimeric cells in maternal health and disease.
Amy Boddy
Co-Principle Investigator
University of California, Santa Barbara
Kroneis is a leader in rare cell analysis at the single cell level and a specialist regarding techniques necessary to sample, unambiguously discriminate and characterize single haplo-identical (i.e., maternal and fetal) cells.
Thomas Kroneis
Co-Principle Investigator
Histologist, Expert for rare cells
Medical University of Graz
Boddy is is a human biologist and evolutionary theorist. Her work integrates maternal/fetal conflict theory, evolution of the placenta and the consequences of fetal microchimeric cells in maternal health and disease.